Beat AML master trial: A clinical trial for acute myeloid leukaemia

BrECADD combined with PET2-guided treatment sets a new benchmark for the treatment of newly diagnosed advanced-stage cHL

The evolving paradigm in management of Multiple Myeloma

Introducing oncology to undergraduate medical and allied health sciences students

Low-dose olanzapine after highly emetogenic chemotherapy can be the new standard of care for solid tumours

Relapsed refractory multiple myeloma

Special issue on real world breast cancer data

Trial investigates multiparametric prognostic score in early HR+/HER2- breast cancer

Patient benefit vs industry benefit finding a balance

Haemato-oncological Cancers

Shared decision making (Patient-oncologist)

Multiple myeloma (A cancer arising from plasma cells)